Surgical Oncology and the Role of Regional Chemotherapy

Trends in surgical oncology research in Australia during the period 1998–2009—a bibliometric review

“…Decreased local recurrence rates may result from treatment by a surgeon with specialty training and interest in a particular cancer. If tumor do recur, these locoregional recurrences may benefit from being treated by a surgeon whose subspecialty expertise allows for the planning and initiation of an appropriate integrative multimodality therapy that is likely to be more effective than a single modality therapy alone [2]. Examples of the later may include isolated limb infusion for in-transit metastatic melanoma of the limb, surgery, and wellplanned adjuvant radiotherapy for retroperitoneal sarcomas, sequencing of surgery and perioperative chemotherapy for colorectal liver metastases and cytoreduction combined with intraperitoneal chemotherapy for peritoneal disease from gastrointestinal and ovarian cancers.…”

Erratum

“…Most importantly, this is practised along with other oncology specialties to integrate and deliver multimodality therapy including systemic chemotherapy and radiotherapy. As indicated by Stephens et al 2, certain malignant diseases have a propensity for widespread dissemination, whilst others have a consistent tendency to recur locoregionally. Decreased local recurrence rates may result from treatment by a surgeon with specialty training and interest in a particular cancer.…”

“…Decreased local recurrence rates may result from treatment by a surgeon with specialty training and interest in a particular cancer. If tumor do recur, these locoregional recurrences may benefit from being treated by a surgeon whose subspecialty expertise allows for the planning and initiation of an appropriate integrative multimodality therapy that is likely to be more effective than a single modality therapy alone 2. Examples of the later may include isolated limb infusion for in‐transit metastatic melanoma of the limb, surgery, and well‐planned adjuvant radiotherapy for retroperitoneal sarcomas, sequencing of surgery and perioperative chemotherapy for colorectal liver metastases and cytoreduction combined with intraperitoneal chemotherapy for peritoneal disease from gastrointestinal and ovarian cancers.…”

Whither surgical oncology?

“…Most importantly, this is practised along with other oncology specialties to integrate and deliver multimodality therapy including systemic chemotherapy and radiotherapy. As indicated by Stephens et al ., 2 certain malignant diseases have a propensity for widespread dissemination, while others have a consistent tendency to recur loco‐regionally. Decreased local recurrence rates may result from treatment by a surgeon with specialty training and interest in a particular cancer.…”

“…Decreased local recurrence rates may result from treatment by a surgeon with specialty training and interest in a particular cancer. Loco‐regional recurrences may also benefit from treatment by a specialist whose expertise allows for the planning and initiation of an appropriate integrative multimodality therapy that is likely to be more effective than a single therapy alone 2 . Examples of the latter may include isolated limb infusion for in‐transit melanoma of the limb, surgery and well‐planned adjuvant radiotherapy for retroperitoneal sarcomas, sequencing of surgery and perioperative chemotherapy for colorectal liver metastases and cytoreduction combined with intraperitoneal chemotherapy for peritoneal metastases.…”